International Summit on Hematology and Blood Disorders

April 27-29, 2023

April 27 -29, 2023 | Online Event

Rare Hematologic Diseases

Rare Hematologic Diseases

A rare disease in the United States is one that affects fewer than 200,000 people in the country. Congress established this definition in the Orphan Drug Act of 1983. Because pharma corporations were not interested in developing medicines for rare diseases, they became known as orphan diseases. The Orphan Drug Act established financial incentives for companies to discover new medicines for uncommon diseases. The definition of rare disease was required in order to determine which disorders would be eligible for the new incentive programmes. Certain cell types can be created in abnormally large quantities or in atypical forms when the usual process of blood cell growth and development breaks down. Blood malignancies and other blood problems arise as a result of this.

Committee Members
Speaker at Hematology and Blood Disorders 2023 - Stefan Gluck

Stefan Gluck

Global Medical Affairs at Celgene Corporation, United States
Speaker at Hematology and Blood Disorders 2023 - A C Matin

A C Matin

Stanford Medical School, United States
Speaker at Hematology and Blood Disorders 2023 - Mohamed Alsharedi

Mohamed Alsharedi

Markey Cancer Center at Lexington Clinic, United States
Hematology 2023 Speakers
Speaker at Hematology and Blood Disorders 2023 - Sanghoon Lee

Sanghoon Lee

Marshall University, United States
Speaker at Hematology and Blood Disorders 2023 - Stefan Gluck

Stefan Gluck

Global Medical Affairs at Celgene Corporation, United States
Speaker at Hematology and Blood Disorders 2023 - Erin Weigel

Erin Weigel

Kedrion Biopharma, United States
Speaker at Hematology and Blood Disorders 2023 - Brandon Lucke Wold

Brandon Lucke Wold

University of Florida, United States

Submit your abstract Today

Watsapp